<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04297514</url>
  </required_header>
  <id_info>
    <org_study_id>REHABGENRE (29BRC20.0030)</org_study_id>
    <nct_id>NCT04297514</nct_id>
  </id_info>
  <brief_title>Effects of Respiratory Rehabilitation by Gender in COPD Patients</brief_title>
  <acronym>REHABGENRE</acronym>
  <official_title>Effects of Pulmonary Rehabilitation According to Gender, in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Without calling into question the effectiveness of pulmonary rehabilitation in women, the
      difference in outcome by gender was not established due to insufficient evidence .

      Studies demonstrating the effectiveness of pulmonary rehabilitation include a majority of
      men, which no longer corresponds to the sex ratio of the disease. The impact of gender on
      pulmonary rehabilitation outcomes was not established due to insufficient evidence.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DYSPNEA-12</measure>
    <time_frame>Change from baseline Dyspnea-12 score at 4 weeks</time_frame>
    <description>Dyspnea-12 allows to evaluate sensori and emotional dyspnea</description>
  </primary_outcome>
  <enrollment type="Anticipated">504</enrollment>
  <condition>COPD</condition>
  <condition>Pulmonary Rehabilitation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients undergoing a pulmonary rehabilitation program
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient &gt; 18 years old

          -  No opposition filed

          -  Patient with COPD

          -  Completed participation in respiratory rehabilitation program

        Exclusion Criteria:

          -  Refusal of participation

          -  Patient under tutorship or curatorship

          -  No final assessment

          -  Patients with sex changes in marital status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Beaumont, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH des pays de Morlaix</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc BEAUMONT, PhD</last_name>
    <phone>0298626160</phone>
    <email>mbeaumont@ch-morlaix.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Beaumont, PhD</last_name>
    <phone>0298626160</phone>
    <email>marc.beaumont@chu-brest.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH des pays de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <zip>29672</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Beaumont, PhD</last_name>
      <email>mbeaumont@ch-morlaix.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 27, 2020</study_first_submitted>
  <study_first_submitted_qc>March 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2020</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>Dyspnea</keyword>
  <keyword>quality of life</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning 6 Months and ending five years following the publication</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

